List of Rayos drug patents

Rayos is owned by Horizon.

Rayos contains Prednisone.

Rayos has a total of 6 drug patents out of which 0 drug patents have expired.

Rayos was authorised for market use on 26 July, 2012.

Rayos is available in tablet, delayed release;oral dosage forms.

Rayos can be used as treatment of rheumatologic, allergic, pulmonary, gastrointestinal, dermatologic diseases or conditions by the use of a delayed release 5mg prednisone tablet, treatment of diseases or conditions by the use of a delayed release 1, 2, or 5 mg prednisone tablet, treatment of diseases or conditions by the use of a delayed-release 1,2, or 5mg prednisone tablet.

The generics of Rayos are possible to be released after 07 January, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8309124 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(1 year, 2 months from now)

US8394407 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(1 year, 2 months from now)

US9040085 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(1 year, 2 months from now)

US9186332 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(1 year, 2 months from now)

US9504699 HORIZON Delayed-release glucocorticoid treatment of rheumatoid disease
Aug, 2027

(4 years from now)

US8168218 HORIZON Delayed release tablet with defined core geometry
Jan, 2028

(4 years from now)

Drugs and Companies using PREDNISONE ingredient

Market Authorisation Date: 26 July, 2012

Treatment: Treatment of diseases or conditions by the use of a delayed release 1, 2, or 5 mg prednisone tablet; Treatment of diseases or conditions by the use of a delayed-release 1,2, or 5mg prednisone tablet; Treatment of rheumatologic, allergic, pulmonary, gastrointestinal, dermatologic diseases or conditions by the use of a delayed release 5mg prednisone tablet

Dosage: TABLET, DELAYED RELEASE;ORAL

How can I launch a generic of RAYOS before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in